The founders of Highland Biosciences Ltd. have spent many years in the development of diagnostic products. Prior to founding the company they worked for large multinational life-science companies. They realised that these organisations whilst highly capable to manufacture on a large scale, have difficulty producing genuinely innovative technology in-house.

Richard Day PhD, BSc,  Managing Director (Co-founder)

Richard has 16 years of experience within the diagnostics/pharma industry and author of several patent applications in the field of biosensors.  He gained his PhD from renowned Cranfield Biotechnology Institute, and worked for Tony Turner, inventor of blood glucose biosensor.  After graduating he worked for GlaxoSmithKline identifying and developing new technologies to accelerate drug discovery and manufacturing.   Most recently he worked for J&J, and was involved with technology development and acquisition.

Emma Green, BEng,  Operations Director (Co-founder)

Emma has 15 years experience of innovating, developing and launching products to market.  She has an Engineering degree from Brunel, and specialised in sensor technology.  Since graduating Emma has worked for TI group, Ford Motor Company and Johnson and Johnson (J&J).  Whilst working for J&J developing medical devices she received awards for innovation as well as becoming a certified Six Sigma “Black Belt”

Brian Warrington PhD, CChem, FRSC,  (Chairman)

Brian joined Smith, Kline and French in 1965 and was appointed Vice President, Technology Development with GlaxoSmithKline in 2000. He has worked as a medicinal chemist on a number of successful drug discovery projects. More recently he has specialized in high throughput technologies and the field of automation. In 2005, Dr. Warrington was awarded the Royal Society of Chemistry's Millennium Silver Medal for High throughput Drug Discovery Methodologies. He is currently a consultant to pharma, biotech and academia.